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ABSTRACT
A method for the preparation of oligonucleotides
containing the mutagenic base 4-0-ethylthymine is
described for the first time. Use of p-nitrophenylethyl
type base protecting groups together with phosphite-
triester solid-phase methodology makes possible the
rapid and efficient preparation of oligonucleotides
bearing 4-0-ethylthymine, while standard base
protecting groups are not compatible with the presence
of this base. Possible applications of this methodology
are discussed.
INTRODUCTION
The carcinogenicity of N-nitroso alkylating agents such as
nitrosoureas and nitrosoamines is believed to be mediated by some
products of alkylation of the nucleobases of DNA in particular
6-0-alkylguanine and 4-0-alkylthymine (1-3). Although major
attention in chemical carcinogenesis was focused on 6-0-
alkylguanines, the mutagenic potential of the 4-0-alkylthymines
has been recently recognized (4) and seems to be related to the
very inefficient repair of 4-0-alkylthymines residues in eukaryotic
cells (5).
In order to study the biological and structural role of 4-0-
alkylthymines in DNA, it is important to develop an efficient
and rapid method to incorporate these analogues in synthetic
DNA. It is well known that these compounds are difficult to be
incorporated into synthetic DNA because they are both acid and
base labile, and very sensitive to nucleophiles like ammonia or
amines or thiols used for the deprotection of synthetic DNA (6).
These problems have been recently solved for the preparation
of oligonucleotides bearing some O-alkylthymines (7,8), but the
proposed methods are not useful for the rest of the 0-alkyl-
thymines.
In this paper, we would like to describe for the first time a
method for the preparation of oligonucleotides containing 4-0-
alkylthymines that could be easily adapted for the synthesis of
oligonucleotides containing any O-alkylthymine and, in general,
to other nucleophile-sensitive base analogues.
RESULTS AND DISCUSSION
Synthesis of the phosphoramidite derivatives
The preparation of 4-0-ethylthymidine containing
oligonucleotides requires the synthesis of the appropiate
derivative. We decided to use solid-phase phosphite-triester
methodology and for that reason we have prepared 5'-0-
(dimethoxytrityl)-4-0-ethylthymidine N,N-diisopropyl-O-
cyanoethyl phosphoramidite (1) (Fig. 1). Starting with DMT-T,
the preparation of the 4-0-ethylthymidine derivative was done
by displacement of the triazolo group of 5'-O-
(dimethoxytrityl)-4-(1,2,4-triazolyl)thymidine with sodium
ethoxide. Previously, the 3'-OH of the nucleoside was protected
with the trimethylsilyl group using trimethylsilyl-1,2,4-triazole.
As the silylating reagent produces 1,2,4-triazole as by-product
the modification of the thymidine can be done immediately
without isolating the protected intermediate. The 3' silyl
protecting group is also easily removed with sodium ethoxide
solution used to displace the triazole group. The phosphitylation
of DMT-TEt was done using 2-cyanoethyl-N,N,N',
N'-tetraisopropylphosphordiamidite (9) giving compound 1.
We have also prepared 5'-O-(dimethoxytrityl-4-(1,2,4-tri-
azolyl)thymidine N,N-diisopropyl-O-cyanoethyl phosphoramidite
(2) using previously described protocols (10). This amidite can
be incorporated into synthetic DNA using standard protocols and,
at the end of the synthesis, 4-0-ethylthymidine can be generated
by displacement of the triazole group with ethoxide ions.
Preliminary studies using standard base protecting groups
4-0-Alkylthymidines can not be introduced in synthetic
oligodeoxynucleotides using standard protocols because they react
with ammonia or amines used for the deprotection giving
5-methylcytidine derivatives (7). Recently, the preparation of
oligonucleotides containing some O-alkylthymines has been
solved by using methoxide ions (DBU solutions in methanol) to
remove the base protecting groups (7,8).
Following this rational, we tried first to prepare
oligonucleotides containing 4-0-ethylthymidine using the standard
cyanoethylphosphoramidites and DBU solution in ethanol for the
deprotection of the amide protecting groups of the bases. The
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Figure 1: Preparation of phosphoramidite derivatives used for the synthesis of 4-O-ethylthymidine containing oligodeoxynucleotides.
oligonucleotide-resin AAGTEtCTG-Resin was treated with a 0.1
M solution of DBU in ethanol at room temperature for a period
of time from 1 to 3 days. When we analyzed the reaction crudes
by HPLC we found in all cases a very complex mixture arising
mainly from incomplete deprotection of the amino groups of the
bases as seen by enzymatic digestion of the different peaks. We
have checked that the rate of deprotection of protected nucleosides
(dCbz, dGibu, dAbz) by DBU is much slower in ethanol than in
methanol. This fact is due to the lower nucleophilicity of ethoxide
ions compared to methoxide ions and indicates that it is not
possible to obtain 4-0-ethylthymine oligonucleotides by the
deprotection of the bases with ethanolic solutions of DBU.
We also considered the possibility to convert 4-0-methyl- into
4-0-ethylthymine containing oligonucleotide. First we treated
4-0-methylthymidine with an ethanolic solution of DBU and with
a solution of sodium ethoxide. We found total conversion of 4-0-
methylthymidine to 4-0-ethylthymidine with a 2 hours treatment
of 4-0-methylthymidine with a solution of sodium ethoxide. No
reaction was observed using an ethanolic solution of DBU. Based
in these results, we prepared the oligonucleotide
5'AAGTMeCTG 3' (where TMe stands for 4-0-methylthymine)
and the oligonucleotide was treated with a variety of ethoxide
solutions (see table 1). The best results were observed when
potassium ethoxide alone and sodium ethoxide with 1 8-crown-6
ether were used. In longer treatments we have observed a similar
HPLC profile but a significant decrease of the total amount of
oligonucleotide. That means that in the best conditions we can
only expect a maximum 50% conversion to the desired
oligonucleotide. That could be enough for some biological
experiments but it is not sufficient to prepare oligonucleotides
Table 1: Studies of the transformation of 4-0-methylthymine to 4-0-ethylthymine
inside of the oligonucleotide 5'-d(AAGTMeCTG) 3'.
Reagent* time Composition (%)
-
-TMe--- -TEt_ -T- -
0.1M EtONa 20 hr 59 27 14
0.1MEtOK 12hr 40 51 9
0. IM EtONa / 18-Crown-6 12 hr 45 55 0
0.1M EtOK / 18-Crown-6 12 hr 91 9 0
*in Ethanol/pgridine (1: 1)
-TMe- -, - -T and - -T- - represent oligonucleotides containing TMe, TEt,
and T respectively
for structural studies. In conclusion we have found that the
standard amide type protecting groups are not convenient for an
efficient preparation of oligonucleotides containing 4-0-
ethylthymine and for that reason a new scheme of protecting
groups had to be developed.
Use of p-nitrophenylethyl type protecting groups
A protecting group suitable for the preparation of oligonucleotides
containing 4-0-ethylthymidine must fulfil the condition that
ethoxide ions are the only nucleophile present during the
deprotection. We have selected the p-nitrophenylethyl (NPE) type
groups developed by Pfleiderer et al. (11-14). This protecting
group has been used as amino protecting group with the
phosphate-triester approach (12), but, so far, the preparation and
use in oligonucleotide synthesis of NPE-protected nucleoside
phosphoramidites has not yet been developed (15). We have
prepared 5 '-O-(dimethoxytrityl)-NPE protected (ANPEOC,
CNPEOC, GNPEOC,NPE) nucleosides (Fig. 2) following previously
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Figure 2: NPE-protected nucleosides.
described methods (11). The preparation of the N,N-diisopropyl-
0-2-cyanoethyl phosphoramidites of these compounds was carried
out following published procedures (9).
In order to find the optimal deprotection conditions to be used
in our case we have treated NPE-protected nucleosides
(dANPEoc, dCNPEoc and dGNPEoc, NPE) with different solutions
of DBU in non-protic solvents (dioxane, pyridine) and a protic
solvent (ethanol/dioxane (1:1)). As it can be seen in table 2,
dGNPEOC, NPE iS more easily deprotected than dANPEOC and
dCNPEOC. In aprotic solvents (pyridine and dioxane) the
deprotection is faster than in ethanol/dioxane. Aproximately,
between 2 and 4 hours are needed to deprotect NPE-nucleosides
in a non-protic solution of DBU and at least 32 hrs using a DBU
solution in ethanol/dioxane (1:1).
The assembly of the oligonucleotides indicated in table 3 were
done either in a home-made manual synthesizer or in a
commercial automatic synthesizer. Coupling yields with the NPE-
protected amidites were similar to those obtained using
commercial amidites. For the introduction of 4-0-ethylthymidine
in the oligonucleotide A we have compared the use of the amidite
of 4-0-ethylthymidine (compound 1) and the amidite of
4-(1,2,4-triazolyl)thymidine (compound 2). We have treated
TTCNPEOCTEtCNPEOCTT-resin with 0.5 M DBU solutions in
pyridine and ethanol/tetrahydrofuran (1: 1) and
TTCNPEOcTtriCNPEOCTT_resin with a 0.5 M DBU solution in
ethanol/tetrahydrofuran (1:1). We found that the treatment with
0.5 M DBU in pyridine could not cleave the succinyl type
oligonucleotide-resin bond. Even after 5 days only 30-40% of
the expected amount of oligonucleotide was released from the
resin. On the other hand, the HPLC chromatograms of the
products obtained from the DBU treatments were very similar
and, as it can be seen in figure 3, consisted of a major peak that
had a correct composition after HPLC analysis of enzymatic
digestions and a minor peak that did not have 4-0-ethylthymidine
but in which 4-0-ethylthymine was dealkylated to thymine.
Afterwards, we studied the deprotection in an oligonucleotide
that contained all the bases together with 4-0-ethylthymine
(sequence B). The product obtained using 0.5 M DBU in
ethanol/tetrahydrofuran was still not satisfactory because a large
amounts of side products were observed. We found that the best
results were obtained when a two-steps deprotection protocol was
used. First, a 6 hrs treatment of the oligonucleotide-resin with
a 0.5M solution ofDBU in pyridine was used to remove the major
part of the protecting groups and eliminate the olefins formed
during the (-elimination process and a second treatment with a
0.5 M DBU solution in ethanol/pyridine (1:1) to liberate the
oligonucleotide from the resin. Using this protocol we have
prepared in a 10 .tmol scale an oligonucleotide containing 4-0-
ethylthymine. In the process of scaling-up we observed that the
removal of the oligonucleotide from the resin was slower than
in small scale and we needed to do 5 treatments of 24 hrs with
the DBU solution in ethanol/pyridine. The HPLC profiles of the
product obtained after deprotection and the HPLC-purified
product are shown in figure 4. The desired decanucleotide was
obtained in a 33 % overall yield (synthesis and purification) and
was characterized by HPLC analysis of the enzymatic digestion
(figure 5). Structural studies with this oligonucleotide are
presently under way in order to stablish the base-pairing
properties of 4-0-ethylthymine.
CONCLUSIONS
The data presented here show that oligonucleotides containing
4-0-ethylthymine can be synthesized in a very efficient way using
NPE-protected nucleosides and the solid-phase phosphite-triester
methodology, while standard amide-type protecting groups failed
in giving the correct product in good yields. The proposed
protocol can be easily adapted to the synthesis of oligonucleotides
containing any O-alkylthymines and other nucleophile-sensitive
base analogues (for example 6-0-alkylguanines (16), 2- and
4-thiouracils (17)) and for this reason the method proposed here
can be of great interest because it opens the possibility to prepare
oligonucleotides containing biologically important analogues.
To our knowledge this is the first time that phosphoramidites
containing NPE base protecting groups have been used for the
preparation of oligonucleotides (15). We have also demonstrated
that the deprotection conditions should be carefully optimized
in order to avoid undesirable side reactions like base alkylation
by the olefins formed during the ,8-elimination process. We think
that some improvements in the nature of the (-eliminating groups
should be done to make the deprotection step faster and perhaps
avoiding the possibility of alkylation of the bases. It is also
important to develop other types of linkages between the
oligonucleotide and the resin in order to completely avoid the
use of nucleophiles (including even ethoxide) to cleave the
linkage. Work in these directions are currently being done.
Finally, another aspect that we wish to point out is that using
NPE protecting groups and the standard succinyl linkage between
oligonucleotide and the resin one could generate by a DBU
treatment in a non-protic solvent (pyridine or dioxane), an
oligonucleotide completely free of protecting groups and still
attached to the solid support. These kind of products could be
of interest for the purification of DNA-binding proteins or the
separation of specific single-stranded DNA fragments from a
complex mixture.
MATERIAL AND METHODS
Abbreviations: AcOEt: ethyl acetate; DBU: 1,8-diaza-
biciclo[5.4.0]undec-7-ene; bz: benzoyl; DMT: 4,4'-dimeth-
oxytrityl; EtOH: ethanol; EtOK: potassium ethoxide; EtONa:
sodium ethoxide; Et3N: N,N,N-triethylamine; ibu:isobutiryl;
MeOH: methanol; NPE: p-nitrophenylethyl; NPEOC: p-
nitrophenylethoxycarbonyl; TEt: 4-0-ethylthymidine; TMe: 4-0-
methylthymidine; Ttri: 4-(1,2,4-triazolyl)thymidine; THF:
tetrahidrofuran.
5'-O-DMT-ANPEOC (11), 5' _0DMT-GNPEOC, NPE (14) and
5' -DMT-Ttri-3' -0-N, N-diisopropyl-O-cyanoethyl
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Table 2: Deprotection (%) of NPEOC, NPE-protected nucleosides as estimated by TLC.
Nucleoside 0.5M DBU/dioxane 0.5M DBU/pyridine 0.5M DBU/ethanol:dioxane 1/1
lhr 2hr 4hr lhr 2hr 4hr 10hr 24hr 32hr
cNPEO 15 50 90 60 total 20 50 80 total
ANPEOC 25 50 90 60 total 20 30 70 90
GNPEOC,NPE 50 65 total 90 total 30 50 80 total
Table 3: 4-0-Ethylthymidine contning sequences prepared with NPE-protected phosphoranidites.
Sequence scale amidite* deprotection conditions
A 5'TTCTEtCTT 3' 0.8 pmol I a) 0.5M DBU in pyridine, 1-5 days
b) 0.5M DBU in EtOH/THF 1:1, 24 hrs
A S5TTCTEtCTT 3' 0.8 jrmol 2 0.5M DBU in EtOH/THF 1:1, 24 hrs
B 57TEtTEtCGACTAGT 3' 0.3 pmol 1 a) 0.5M DBU in EtOH/pyr 1:1, 24 hrs,
b) i) 0.5M DBU in pyr 1:1, 6hr followed
by ii) 0.5M DBU in EtOH/pyr 1:1, 12 hrs
C 5'G6GTTEtTTCCG 3' 10 pmol I i) 0.5M DBU in pyr, 6hrs followed by
ii) 0.5M DBU in EtOH/pyr 1:1,
5 treatments of 24 hrs.
* Phosphoramidite used for the incorporation of 4-0-ethylthymnidine
phosphoramidite (10) were prepared as previously described.
5'-O-DMT-CNPE°c was prepared following the methodology
described by Pfleiderer with the only modification that p-
nitrophenylethoxycarbonyl-N-methylimidazolium chloride (11)
was used instead of p-nitrophenylethoxycarbonyl benzotriazole
(11) as acylating reagent. Standard cyanoethyl phosphoramidites
were purchased from Applied Biosystems. Oligonucleotide
syntheses were done either in a home-made manual DNA
synthesizer or in an automatic Applied-Biosystems DNA
synthesizer.
5'-O-(4,4'-dimethoxytrityl)-N,O-(NPEOC, NPE)pro-
tected-2' -deoxyribonucleoside-3' -O-(N ,N-diiso
propyl)-O-2-cyanoethyl phosphoramidites.
0.6 mmols of 5'-O-(4,4'-dimethoxytrityl)-N,O-(NPEOC, NPE)
protected-2'-deoxynucleoside were dried by coevaporation with
anhydrous acetonitrile (2 x5 mL). The residue was dissolved in
anhydrous acetonitrile (1.2 mL) and a 0.4 M solution of tetrazole
in anhydrous acetonitrile (1.5 mL, 0.6 mmol) was added together
with 0.15 mL of 2-cyanoethyl-N,N,N',N'-tetraisopropylphos-
phordiamidite (0.5 mmol) under an argon atmosphere. A white
precipitate of N,N-diisopropylammonium tetrazolate soon
appeared. After 1 hr, a solution of 5% triethylaniine in
chloroform was added and the mixture was washed with a 10%
sodium bicarbonate solution (2x) and a saturated sodium chloride
solution. The organic phase was dried with anhydrous sodium
sulphate and evaporated to dryness. The oily product was
dissolved in the mniimum amount of dichlorometiane and added
to a cold solution of hexane with stirring. The white precipitate
formed was separated by centrifugation and dried in vacuo.
Phosphoramidite
ANPEOC
CNPEOC
GNPEOC, NPE
Yield TLC Rf*
70% 0.40
70% 0.42
50% 0.86
31P-NMR (Cl3CD, 81 MHz)
146.5, 146.4 ppm
146.9, 146.4 ppm
146.4, 146.2 ppm
*AcOEt/CH2Cl2/Et3N (45:45:10)
5'-O-(4,4'-dimethoxytrityl)-4-O-ethylthymidine.
5'-O(4,4'-dimethoxytrityl)thymidine (1.5 g, 2.6 mmol) was dried
by coevaporation with anhydrous acetonitrile (2 x 10 mL). The
residue was dissolved with 60 mL of anhydrous acetonitrile and
1-trimethylsilyl-1,2,4-triazole (0.78 g, 5.5 mmol) was added
I I I0 5 10 15 210 2 min
Figure 3: HPLC purification of heptanucleotide A (TTCTEtCTT) prepared with
NPEOC-protected and 4-0-ethylthymidine phosphoranidites after the treatnent
with 0.5 M DBU in EtOH/THF 1:1 being I: TrCTCTT and II: TTCTEICTT.
Inserts show HPLC analysis of the enzymatic digestions of peak I and II.
under argon atmosphere. The mixture was kept at 50°C during
1 hr and allowed to cool down to room temperature. The resulting
solution was added to a mixture previously prepared in the
following way: A suspension of 1,2,4-triazole (1.9 g, 27.6 numol)
in 48 mL of anhydrous acetonitrile was cooled in an ice-bath
and 0.54 mL of phosphorous oxychloride (6.3 mmol) were added
with stirring, together with 4.15 mL of triethylamine (30 mmol).
The mixture was stirred for 30 minutes at 0°C before 3'-O-
TMS-5'-O-DMT-thymidine was added.
After 2 hrs of magnetic stirring at room temperature, the
reaction mixture was diluted with dichloromethane and washed
with a 10% sodium bicarbonate solution. The organic phase was
dried with anhydrous sodium sulphate and evaporated to dryness.
The product was dissolved in 20 mL of absolute ethanol and 20
mL of a 0.08 M solution sodium ethoxide were added. The
A260 T A260 T
pak I peak I
dC
0 5 115 26 1 1 01 20 5
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Figure 4: HPLC purification of decanucleotide C (GGGTTEt'TTCCG). In the
insert, analytical HPLC of the purified product.
solution was stirred for 30 min, neutralized with 0.2 mL of glaciar
acetic acid and evaporated to dryness. The product was purified
on a silica gel column eluted with a solution from 0% to 5%
of methanol in dichloromethane.
Fractions containing the desired product were pooled and
evaporated to dryness. The oily product was dissolved with the
minimal amount of dichloromethane and precipitated from a
mixture of ethyl ether / hexane (1:1), obtaining 0.42 g of a white
solid (67% yield), m.p. 86-92°C. Homogenous by TLC
(CH2Cl2/MeOH 90:10) Rf= 0.48. UV (MeOH) max. 275.1 nm
(log e 3.60). IH-NMR (DMSO-d6, 200 MHz) 6 (ppm) = 7.9
(1H, s, H-5); 7.3 (9H, m, Ar); 6.9 (4H, m, Ar); 6.2 (1H, t,
H-l'); 5.4 (1H, d, 3'-OH); 4.3 (3H, m, -OCH2-CH3, H-3'); 3.9
(lH, m, H4'); 3.4 (2H, m, H-5'); 2.87 (3H, s, -OCH3); 2.85
(3H, s, -OCH3); 2.2 (2H, m, H-2'); 1.5 (3H, s, -CH3); 1.15
(3H, t, -O-CH2-CH3).
5'-O-(4,4'-Dimethoxytrityl)4-O-ethylthymidine-3'-O-(N,N-
diisopropylamino) 2-cyanoethyl phosphoramidite
0.3 g of 5'-O-(4,4'-dimethoxytrityl)4-O-ethylthymidine (0.52
mmol) were reacted in acetonitrile with 35.2 mg of tetrazole (0.50
mmol) and 1.143 mL of 2-cyanoethyl-N,N,N',N'-tetraisopropyl-
phosphordiamidite (0.5 mmol) under a dry argon atmosphere as
described above. The resulting product was dessicated and stored
under argon at -20 'C. It weighed 0.40 g (85% yield) and was
used without further purification. TLC (AcOEt/CH2Cl2/Et3N
45:45: 10) Rf 0.6. 31P-NMR (CDC13, 81 MHz); 6 (ppm): 148.8,
148.5.
Oligonucleotide syntheses
All the oligonucleotides were synthesized using standard solid-
phase phosphite-triester procedures. Oligonucleotide C was
prepared on a 10 zmol scale and using an automatic DNA
synthesizer. The rest of the oligonucleotides were synthesized
on a 0.3-1 ,umol scale using a manual synthesizer. The support
used in all the syntheses was long-chain amino alkyl controlled-
pore glass that was functionalized following the methodology
described in ref. 18 with the only modification that N-
0 5 10 1i 2b 2 miin
Figure 5: HPLC analysis of the enzymatic digestion of oligonucleotide C.
methylimidazole was used as catalyst in the preparation of the
DMT-nucleoside succinates instead of N,N-dimethyl-
aminopyridine.
Deprotection and purification
In a typical experiment 10-20 mg of oligonucleotidyl-resin were
treated with aprox. 0.5 mL of the appropiate DBU solution. After
a period of time ranging from 12 to 72 hrs, the resin was filtered
and washed with the same solvent used for the deprotection. The
filtrates were pooled, neutralized with acetic acid (1.5 equiv. with
respect to the amount of DBU) and diluted with aprox. 10 mL
of water. The aqueous phase was washed with ether, CH2Cl2,
and ether and concentrated to dryness. The residue was dissolved
in water and chromatographed on a Sephadex G-10 column
(30 x 1 cm) eluted with 50 mM triethylammonium bicarbonate.
The fractions corresponding to the first UV-absorbing peak were
pooled and lyophilized. The resulting residue was purified by
reversed-phase HPLC using a C-18 Nucleosil (5itm) column
(250 x4 mm) with a 5-30% gradient of acetonitrile in 10 mM
triethylammonium acetate over 20 min.
In the 10 ymol preparation of 5'-d(GGGTTEtTTCCG), 400
mg of the resin were treated twice with 10 mL of a 0.5 M DBU
solution in acetonitrile at room temperature for 3 hrs. Afterwards,
the resin was washed with acetonitrile and treated with 10 mL
of a 0.5 M DBU solution in EtOH/pyridine (1: 1). After 24 hrs,
the solution was filtered from the resin, and the resin was washed
with pyridine. The collected filtrates were pooled, neutralized
with 0.15 mL of acetic acid and diluted with 3 mL of a 50 mM
aqueous solution of triethylammonium bicarbonate. The treatment
of the resin with 0.5M DBU in EtOH/pyridine was repeated until
no more oligonucleotide was cleaved from the resin (a total of
5 treatments were needed). The filtrates were pooled and
evaporated to dryness. The residue was chromatographed on a
Sephadex G-10 column obtaining 550 OD units at 260 nm of
a crude material that was purified by reversed-phase HPLC using
a y-Bondapak C-18 (5gm) column (150 x 19 mm). Flow rate:
5 mL/min. Solution A: 50 mM triethylammonium acetate;
solution B: acetonitrile/water (1:1). A 20 min gradient from 5
to 30%B was used. Yield: 240 OD units at 260 nm (33% yield).
The product was characterized by its nucleoside content.
Synthesis of 5'-d(AAGTEtCTG) 3' by alkoxy exchange at the
oligonucleotide level
DMT-AAGT,riCTG-resin was prepared with standard
phosphoramidites as described above. 10 mg of the resin were
A20 A260
0 5 10 15
-1 I .r . .it I
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treated with a solution ofDBU/MeOH/THF (1:3:3 vlvlv) at room
temperature for 60 hrs. After the work-up described above, the
resulting DMT-oligonucleotide was purified by reversed-phase
HPLC, treated with 80% acetic acid and rechromatographed. The
product 5'-d(AAGTMeCTG) was characterized by its nucleoside
content analysed by enzymatic hydrolysis followed by HPLC
analysis of the digestion.
Purified AAGTMeCTG (0.5 OD units at 260 nm) was treated
with the appropriate ethoxide solution (see table 1). At different
times, acetic acid (1 equivalent with respect to the amount of
ethoxide) was added and the mixture was concentrated to dryness.
The residue was purified by gel filtration chromatography on a
Sephadex G-10 column (30x 1 cm) eluted with 50 mM
triethylammonium bicarbonate followed by reversed-phase HPLC
using a C-18 Nucleosil (5 /m) column (250 x4 mm) with a
0 -20% gradient of acetonitrile in 50 mM triethylammonium
acetate over 15 min, and 5 min isocratic at 20% acetonitrile. The
elution times were as follows : AAGTCTG, 14.5 min;
AAGTMeCTG, 15.0 min; and AAGTEtCTG, 15.5 min. All the
products were characterized by its nucleoside content.
Deprotection of NPEOC, NPE-protected nucleosides
Approx. 1-2 mg of NPEOC,NPE-protected nucleosides were
dissolved in 0.2 mL of0.5M DBU solutions in dioxane, pyridine
and ethanol/dioxane (1:1) with stirring, At different times,
aliquots were taken, and were analyzed immediately by TLC
(dichloromethane/methanol (9: 1)). Results are shown in table 2.
Enzymatic digestions of oligonucleotides
The polymers (0.5 OD at 260 nm) were incubated in 50 mM
tris.HCl pH 8.0 and 10 mM magnesium chloride with snake
venom phosphodiesterase (0.4 ,ug) and bacterial phosphatase (0.4
,tg) in a total volume of 20 $L at 37°C overnight. The resulting
mixture was diluted and analyzed by HPLC. Column: C-18
Nucleosil (5 jAm). Flow rate: 1 mL/min. Solvent A: 10 mM
triethylammonium acetate, solvent B: acetonitrile/water (1:1).
A 20 min linear gradient from 0%B to 50%B. The retention times
observed under these conditions were dC 6.7 min, dG 9.8 min,
T 10.2 min, dA 12.4 min, TMe 15.5 min, TEt 19.8 min.
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